article thumbnail

The first major set of genetic associations found in long COVID

Drug Target Review

About the author Dr Sayoni Das SVP Bioinformatics at PrecisionLife Sayoni leads the research and development of bioinformatics pipelines that generate biological insights from PrecisionLife’s core technology and support drug discovery programmes.

article thumbnail

Genomic score predicts patients' progression to multiple myeloma

Broad Institute

Treating risk as simply high or low fails to capture the complexity of tumor timing and evolution, and we saw an opportunity to redefine it through whole-genome sequencing, said Alberge. These insights wouldn't be possible without access to deeply sequenced whole genomes from a large number of patients and across different disease stages."

DNA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unlocking the potential of natural products in drug discovery

Drug Target Review

She came to Bruker in 2021 from a faculty position in the Department of Chemistry at San Diego State University following a post-doctoral fellowship at The Scripps Research Institute in Gary Siuzdak’s group. Her major focus has been untargeted metabolomics method development and bioinformatics solutions for structure elucidation.

article thumbnail

A scientist devotes her career to tackling inequity in genomics

Broad Institute

She thought about becoming a doctor when she moved to Seattle for college, but wanted to go beyond treating symptoms to make a longer-term impact on human health. Alicia Martin and attendees of the KEMRI-Wellcome Trust/GINGER Bioinformatics training in Kilifi, Kenya in September 2018. And this has been the goal of her work ever since.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Bioinformatics is all about bringing together different areas of knowledge. Do you think the current talent pool supply meets the demand?

article thumbnail

#WhyIScience Q&A: A systems biologist develops computational tools to bring scale to cell experiments

Broad Institute

At first, Yue Qin thought she wanted to become a doctor. After graduating with a bachelor’s degree in bioinformatics, Qin then went on to pursue her PhD at UCSD, where she used computational modeling to study how proteins interact with each other and assemble into a human cell.

Science 69
article thumbnail

Not all neoantigens are created equal

Drug Target Review

Recent advances in bioinformatics show clonal neoantigens are the best targets for immunotherapy, as I will elucidate below. Using powerful bioinformatics technology developed and validated with sequence data from the TRACERx study, researchers are able to identify clonal neoantigens from a patient’s unique tumour profile.